Telix Pharmaceuticals Ltd News

Telix Pharmaceuticals Ltd: Telix Files Form 20-F Registration Statement for Nasdaq ADS

Oct 17 17:21 ET

Telix Pharmaceuticals Ltd: Appendix 3Z Final Director Notice (A Kluge)

Oct 17 02:10 ET

Telix Pharmaceuticals Ltd: Andreas Kluge to Retire from Telix Board

Oct 17 02:10 ET

Telix Pharmaceuticals Ltd: Telix Q3 2024 Revenue and Business Update

Oct 17 02:08 ET

Telix Pharmaceuticals Ltd: Notification of cessation of securities - TLX

Oct 7 17:26 ET

Telix Pharmaceuticals Ltd: Application for quotation of securities - TLX

Oct 7 17:25 ET

Telix Pharmaceuticals Ltd: Application for quotation of securities - TLX

Sep 25 18:25 ET

Telix Pharmaceuticals Ltd: Telix to Acquire RLS for US Manufacturing and Distribution

Sep 22 18:25 ET

Telix Pharmaceuticals Ltd: Notification regarding unquoted securities - TLX

Sep 10 18:21 ET

Telix Pharmaceuticals Ltd: Application for quotation of securities - TLX

Sep 8 18:26 ET

Telix Pharmaceuticals Ltd: Becoming a substantial holder

Aug 30 04:35 ET

Telix Pharmaceuticals Ltd: Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent

Aug 27 18:17 ET

Telix Pharmaceuticals Ltd: Telix Reorganisation to Deliver on Strategic Priorities

Aug 26 18:08 ET

Telix Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 22 04:10 ET

Telix Pharmaceuticals Ltd: Securities Dealing Policy - Updated

Aug 22 03:23 ET

Telix Pharmaceuticals Ltd: Telix 1H 2024 Results Presentation

Aug 22 02:42 ET

Telix Pharmaceuticals Ltd: Telix 1H 2024 Results Release

Aug 22 02:41 ET

Telix Pharmaceuticals Ltd: Telix 1H 2024 Appendix 4D and Interim Report

Aug 22 02:40 ET

Telix Pharmaceuticals Ltd: Becoming a substantial holder

Aug 21 04:07 ET

Telix Pharmaceuticals Ltd: Ceasing to be a substantial holder

Aug 14 00:47 ET